X-Chem

Activities: Digital

Trending Articles

  1. IMPACT CKD model reveals the escalating toll of chronic kidney disease The model projects up to 125 million of the population across eight countries to suffer from chronic kidney disease by 2032
  2. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  3. Isospec Analytics launches biomolecular analysis technology to identify unknown molecules The novel technology optimises the identification process of unknown molecules compared to mass analysis
  4. Building strong foundations for a resilient and planet-friendly future Having recently released its inaugural environmental, social and governance (ESG) report, Dr Kevin Robinson caught up with Gigi Bat-Erdene, Global ESG Program Manager at PCI...
  5. ten23 health and Ypsomed collaborate to commercialise the YpsoDose patch injector The partnership will bring the drug delivery device to the pharmaceutical market quicker, whilst reducing development risks

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

Research & Development

X‑Chem transitions executives into new roles, appoints new Chief Executive Officer

X-Chem, the leading provider of innovative solutions in early-stage drug discovery, today announced executive management team changes aimed at expanding its position as a premium provider of integrated services to drug hunters
Research & Development

X-Chem announces achievement of collaboration milestone

X-Chem, a global leader in innovative drug discovery services, announces the achievement of a drug discovery milestone, following a partner’s attainment of a development candidate
Drug Delivery

X-Chem expands drug partnership with Kymera Therapeutics

Kymera is advancing a pipeline of novel therapeutic candidates designed to address the most promising targets and provide patients with more effective treatments
Finance

X-Chem and Excelra link up on drug discovery

The partnership, utilising Excelra’s GOSTAR and X-Chem’s RosalindAI platforms, will improve capabilities to predict small molecules, chemical, biological, and physical properties
Finance

X-Chem acquires European synthetic chemistry specialist

The acquisition of ComInnex will improve X-Chem's flow chemistry, photochemistry and software development capabilities
Research & Development

X-Chem collaborates with AstraZeneca

Small molecule discovery specialist X-Chem, announced a significant expansion of its existing global drug discovery collaboration with the global biopharmaceutical company AstraZeneca

X-Chem
Subscribe now